Lamsin, Jessa .

HRN: 24-15-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2023
AMPICILLIN 1GM (VIAL)
12/24/2023
12/25/2023
IVT
2 Gm
Q6h
PROM X 3 Hours; Thickly MSAF
Waiting Final Action 
12/25/2023
CEFUROXIME 500MG (TAB)
12/25/2023
01/01/2024
PO
500 Mg Tab
BID
PROM X 4 Hours; Thickly MSAF
Waiting Final Action 
12/25/2023
METRONIDAZOLE 500MG (TAB)
12/25/2023
01/01/2024
PO
500 Mg Tab
TID
PROM X 4 Hours; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: